Latest Corporate News
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
BioMarin agreed to buy Amicus Therapeutics in a deal valued at $4.8 billion, adding two commercial treatments to BioMarin’s portfolio and strengthening its rare-disease pipeline. The transaction was announced with Kirkland & Ellis advising Amicus on the sale
.
Trump Media & TAE Technologies Complete Landmark Merger Valued > $6B
Trump Media & Technology Group Corp. merged with fusion firm TAE Technologies in a transaction valued at more than $6 billion, creating one of the first publicly traded fusion companies, with DLA Piper advising on the deal. The all‑stock merger positions the combined company at the intersection of media and advanced energy technology
.
Woori IO Shareholders Approve Exchange to Become OSR Holdings Subsidiary
Woori IO shareholders approved a share exchange to become a wholly owned subsidiary of OSR Holdings’ Korean holding company, enabling integration into OSR Group and accelerating regulatory and clinical plans. Woori IO is collaborating with Samsung on a proof‑of‑concept and plans a U.S. FDA trial with a leading California research university
.
Top Executive‑Search Firms Continue Hot M&A Wave in 2025
Consolidation in executive search remained strong in 2025, with multiple notable acquisitions including Egon Zehnder’s purchase of The Prince Houston Group and ZRG’s acquisitions to broaden sector coverage, reflecting buyers’ focus on specialized, scalable talent platforms. Hunt Scanlon’s roundup highlights deal activity across financial services, healthcare, education and tech recruiting
.
Burke & Herbert to Acquire Linkbancorp in $354.2M All‑Stock Deal
Alexandria-based Burke & Herbert Financial Services agreed to acquire Pennsylvania’s Linkbancorp in an all‑stock transaction worth about $354.2 million, creating a combined holding company with roughly $11 billion in assets and an expected close in Q2 2026. Link shareholders will receive 0.135 Burke & Herbert shares per Link share, with pro forma ownership split ~75%/25%
.
Air Lease Shareholders Approve Proposed Takeover
Air Lease secured shareholder approval for a proposed acquisition by a Dublin-based holding company, clearing a major hurdle toward the aircraft lessor’s sale and moving the transaction toward closing. The vote advances the bidder’s plans to consolidate Air Lease under the acquiring group
.
American Drive Acquisition Company Closes $230M IPO
American Drive Acquisition Company closed an initial public offering raising approximately $230 million, marking another SPAC/blank‑check financing closing in 2025. The offering was announced via PR channels and will support the sponsor’s search for combination targets
.
Legal Advisor DLA Piper Guides High‑Profile Merger Counsel
Global law firm DLA Piper announced its role representing Trump Media & Technology Group in the transaction with TAE Technologies, underscoring continued heavy involvement of major law firms in high‑value cross‑sector deals. Their advisory role highlights the legal complexity of combining media and advanced technology businesses
.
M&A Trends Preview: Hostile Bids and Strategic Overbids Mark 2025
DealLawyers’ M&A trends coverage notes a rise in hostile and unsolicited offers during 2025, citing examples that shaped corporate activity and informing expectations for 2026 strategic behavior. The write‑up highlights valuation shifts and shareholder dynamics driving aggressive bidding
.
EIN Presswire: Multiple Corporate Press Releases Published Today
EIN Presswire’s December 20 press release feed aggregates several corporate announcements, including consumer, retail and B2B product releases timed for the holiday season and year‑end communications. The feed reflects routine corporate PR volume during year‑end business cycles
.
Global Capital Flows and Corporate Impacts Highlighted in Economic Commentary
An opinion piece in The Manila Times discusses large nonresident capital flows into emerging markets in 2025 and the implications for corporate investment and M&A activity globally. The article frames the flows as part of a broader rebalancing with potential strategic consequences for multinationals
.
Kirkland Advises on Significant Life Sciences Transaction
Kirkland & Ellis announced it advised Amicus Therapeutics in the sale to BioMarin, illustrating continued large-scale advisory work in the biopharma M&A market and the strategic consolidation of rare‑disease assets. The deal strengthens BioMarin’s commercial portfolio with near‑term product additions
.